Source: Annual Congress 2011 - Biomarkers in sarcoidosis



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bargagli, D. Bennett, C. Maggiorelli, M. G. Pieroni, R. M. Refini, M. G. Perari, P. Rottoli (Sienna, Italy). Chitotriosidase: A sensitive biomarker of sarcoidosis. Eur Respir J 2011; 38: Suppl. 55, 4518

Member's Comments

No comment yet.

Related content which might interest you: Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker? Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 IPF: clinical profiles Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis Year: 2010 Are blood inflammatory markers useful in characterising children with severe asthma (SA)? Source: Annual Congress 2010 - Fibre-optic bronchoscopy and bronchoalveolar lavage in the treatment of paediatric respiratory diseases Year: 2010 SHOX2 DNA methylation is a promising biomarker for the diagnosis of lung cancer in plasma Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Chitotriosidase: a marker and modulator of lung disease Source: Eur Respir Rev, 29 (156) 190143; 10.1183/16000617.0143-2019 Year: 2020 Sarcoidosis: serum and imaging biomarkers Source: Eur Respir Monogr 2022; 96: 107-121 Year: 2022 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Biomarkers in pulmonary fibrosis Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 KL-6 is a useful serum biomarker for early detection of interstitial lung disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Effects of erdosteine on serum biomarker concentrations at COPD exacerbation Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 The diagnosis of IPF: recommendations & rationale Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Biomarkers in asthma and COPD Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 Non invasive biomarkers in the diagnostic and prognostic evaluation of Pulmonary Fibrosis Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020